Clinical Trials · NCT07732218
Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Rehman Medical Institute - RMI
- Enrollment
- 95
- Start date
- Jul 2022
- Locations
- 1 site, Pakistan
- Primary endpoint
- Change in Glycated hemoglobin